O. Schmitz

Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.

J. Holst, W. März, W. Schmiegel, 2001, Diabetes.

Bedtime Administration of NN 2211 , a Long-Acting GLP-1 Derivative , Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes

J. Sturis, J. Veldhuis, O. Schmitz, 2002 .

Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations

J. Holst, M. Walker, J. Sturis, 1999, Diabetologia.